Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2026-02-03 @ 5:03 AM
Study NCT ID:
NCT00737360
Status:
TERMINATED
Last Update Posted:
2012-09-05
First Post:
2008-08-18
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of TAS-106 to Treat Head and Neck Cancer
Sponsor:
Taiho Pharmaceutical Co., Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
TAS106-9905
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None